Angiotensin II (Ang II) activates cytosolic Ca 2ϩ -dependent phospholipase A 2 (cPLA 2 ), phospholipase D (PLD), p38 mitogen-activated protein kinase (MAPK), epidermal growth factor receptor (EGFR) and Akt in vascular smooth muscle cells (VSMC). This study was conducted to investigate the relationship between Akt activation by Ang II and other signaling molecules in rat VSMC. Ang II-induced Akt phosphorylation was significantly reduced by the PLD inhibitor 1-butanol, but not by its inactive analog 2-butanol, and by brefeldin A, an inhibitor of the PLD cofactor ADP-ribosylation factor, and in cells infected with retrovirus containing PLD 2 siRNA or transfected with PLD 2 antisense but not control LacZ or sense oligonucleotide. Diacylglycerol kinase inhibitor II diminished Ang II-induced and diC8-phosphatidic acid (PA)-increased Akt phosphorylation, suggesting that PLD-dependent Akt activation is mediated by PA. Ang II-induced EGFR phosphorylation was inhibited by 1-butanol and PLD 2 siRNA and also by cPLA 2 siRNA. In addition, the inhibitor of arachidonic acid (AA) metabolism 5,8,11,14-eicosatetraynoic acid (ETYA) reduced both Ang II-and AAinduced EGFR transactivation. Furthermore, ETYA, cPLA 2 antisense, and cPLA 2 siRNA attenuated Ang II-elicited PLD activation. p38 MAPK inhibitor SB202190 [4-(4-flurophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] reduced PLD activity and EGFR and Akt phosphorylation elicited by Ang II. Pyrrolidine-1, a cPLA 2 inhibitor, and cPLA 2 siRNA decreased p38 MAPK activity. These data indicate that Ang II-stimulated Akt activity is mediated by cPLA 2 -dependent, p38 MAPK regulated PLD 2 activation and EGFR transactivation. We propose the following scheme of the sequence of events leading to activation of Akt in VSMC by Ang II: Ang II3cPLA 2 3 AA3p38 MAPK3 PLD 2 3 PA3 EGFR3 Akt.Akt, a serine/threonine kinase, contains N-terminal pleckstrin-homology domain, a kinase domain, and a C-terminal regulatory domain (Shiojima and Walsh, 2002). Cytokines and several growth factors, including angiotensin II (Ang II), stimulate the conversion of phosphatidylinositol(4,5)bisphosphate to phosphatidylinositol(3,4,5)trisphosphate through activation of phosphatidylinositol 3-kinase (PI3K) (Shiojima and Walsh, 2002). Phosphatidylinositol(3,4,5)trisphosphate binds to the pleckstrin-homology domain of Akt, recruits Akt to the plasma membrane, and exposes Akt to phosphorylation at serine 473 in the regulatory domain and at threonine 308 in the kinase domain by 3-phosphoinositide-dependent protein kinases, which associates with protein kinase C-related kinase-2 (Shiojima and Walsh, 2002). Phosphorylated and activated Akt stimulates several downstream effectors including Bad, forkhead transcription factor, IKK␣, E2F, Gsk3, p70S6K, hTERT, eNOS, and